NICE publishes new rapid guideline to diagnose and treat rare blood clotting condition associated with COVID-19 vaccination

NICE has today published a new rapid COVID-19 guideline to help healthcare staff identify and treat patients who develop the rare syndrome vaccine-induced immune thrombocytopenia and thrombosis (VITT) after receiving COVID-19 vaccinations.
Go to the profile of OnMedica
Jul 29, 2021